ABSTRACT: An epizootic of vesicular disease occurred in a group of semi-domesticated California sea lions (Zalophus californianus) during the months of April and May 1997. Ten castrated mature male sea lions, ages 12 to 19 yr, were housed in three adjacent open-ocean net enclosures in San Diego Bay (California, USA). Four animals (40%) developed oral and extremity vesicles, anorexia, and were reluctant to perform learned behaviors. One animal developed vesicles but maintained a normal appetite and behavior. The remaining animals showed no clinical signs of infection. Virus (designated FADDL 7005) was isolated from four of the five animals that developed vesicles. Serum antibody titers to FADDL 7005, a previously untyped calicivirus, were demonstrated in animals that showed any combination of clinical signs and in two animals that did not show any clinical signs. No virus was isolated from five fecal samples collected from four of the group animals. Clinical signs lasted 4 to 20 days in affected animals. All affected animals recovered from infection. An experimental swine was inoculated with FADDL 7005 and developed vesicular disease, which was transmitted to another experimental swine upon contact. It is proposed that FADDL 7005 is a new San Miguel sea lion virus.
INTRODUCTION
Calicivirus infection was first reported in California sea lions (Zalophus californianus) in 1972. The virus, designated San Miguel Sea Lion Virus (SMSV), was the first isolated from a pinniped species and has been shown to be indistinguishable from the causative agent of vesicular exanthema of swine (VES) (Smith et al., 1973; Sawyer, 1976) . Vesicular exanthema of swine has not been reported in the United States since 1956 and was declared eradicated in that species in 1959 (Smith and Akers, 1976) . At least 34 serotypes of calicivirus have been determined to be of ocean origin (Smith and Boyt, 1990 ). The potential relationship of caliciviruses of marine origin to VES virus, and the potential interspecies transmission of caliciviruses, have been the subject of much investigation and speculation (Prato et al., 1974; Smith et al., 1978 Smith et al., , 1983 Smith et al., , 1998 Smith and Boyt, 1990) .
There are few reports of the natural course of calicivirus infection in pinnipeds. Gage et al. (1990) described the case history of a California sea lion that developed vesicular lesions, from which a calicivirus was isolated. They also described 31 other sea lions presenting to The Marine Mammal Center (Sausalito, California, USA) with vesicular lesions during an epizootic of leptospirosis in 1984. They reported 32/ 239 (13%) of California sea lions presenting that year with vesicular lesions suggestive of calicivirus infection. More recent estimates of the prevalence of these lesions in pinnipeds at that facility are three to four times higher (F. M. Gulland, pers. comm.). In contrast, vesicular lesions of pinnipeds presenting as stranded animals to Sea World of California (San Diego, California, USA) are rare (T. Reidarson, pers. comm.) .
This report describes the clinical signs of infection with and the isolation of a serotype of calicivirus, designated FADDL 7005, in a group of semi-domesticated California sea lions housed in San Diego bay. The experimental transmission of the isolate to swine and resulting disease, in- distinguishable from vesicular exanthema of swine, is also described.
MATERIALS AND METHODS

Clinical procedures
Ten castrated mature male California sea lions (Zalophus californianus), ages 12 to 19 yr, were housed in three adjacent open-ocean net enclosures in San Diego Bay (32Њ42.3ЈN, 117Њ14.2ЈW). All animals were employed in the U.S. Navy Marine Mammal Program (San Diego, California, USA) as open-ocean deep-sea recovery animals and routinely worked at various locations along the southern California coast outward to San Clemente Island (32Њ58.8ЈN, 118Њ32.3ЈW). The animals were fed daily rations of various fish species from worldwide sources including sardines (Sardinops sagax caerulea), mackerel (Scomber japonicus or Pneumatophorus diego), and squid (Illex sp.) from southern California fisheries.
On 8 April 1997 one of the group animals, NIC, was brought to the attention of the veterinary staff with the complaint of poor appetite and reluctance to perform learned behaviors. The following day an erupted vesicle was noted on the sea lion's tongue and calicivirus infection was suspected. Whole blood and serum samples were collected with the animal restrained in a squeeze cage. Amoxicillin (SmithKline Beecham Pharmaceuticals, Philadelphia, Pennsylvania, USA) at 15 mg/kg and clindamycin (The Upjohn Company, Kalamazoo, Michigan, USA) at 12 mg/kg orally, twice daily, were prescribed. On 12 April this animal subsequently developed multiple vesicles of the hard palate and dorsal surface of the tongue, which were causing obvious discomfort (Figs.  1, 2) . The animal stayed out of the water with mouth open and refused all fish offered. Topical application of local anesthetic spray (Cetylite Industries, Inc. Pennsauken, New Jersey, USA) did not improve its condition.
The sea lion was restrained in a squeeze cage, masked down with Isoflurane (Ohmeda Caribe, Inc. Liberty Corner, New Jersey, USA), and the largest oral vesicle (ϳ3.5 cm 2 ) aspirated with a 22 gauge needle. The vesicular fluid and a biopsy of the overlying epithelial tissue collected with iris scissors were transferred immediately to viral transport medium (Multi-Microbe Medium [M4] Micro Test Inc, Liburn, Georgia USA) and stored at approximately 5C. The samples were shipped the following day on cold packs to the Foreign Animal Disease Diagnostic Laboratory (FADDL, Plum Island, New York, USA) for virus isolation attempts. Whole blood, serum, and fecal samples were also collected. The animal recovered uneventfully, was returned to the group enclosure, and was eating well the following day. On 17, 18, 22, and 24 April, additional vesicles developed on the superior hairless surfaces of this animal's flippers and each was aspirated with a 21 gauge butterfly catheter (Becton Dickinson Vascular Access, Sandy, Utah, USA). The vesicular fluid was transferred immediately to viral transport media and submitted to FADDL. Several erupted vesicles were also swabbed with sterile dacron swabs, the swab immediately transferred to viral transport media and submitted to FADDL. The animal's appetite remained normal after 12 April and it was returned to work. Antibiotics were discontinued on 21 April. All vesicular lesions were completely healed by 29 April.
Four additional group animals developed vesicular lesions and three of these were also anorexic. On 14 and 16 April, respectively, ZAC, LIB, and DUK had poor appetites. In each case, vesicles developed one to fourteen days following onset of poor appetite and vesicular fluid was collected opportunistically. In two of these cases, LIB and DUK, confirmed oral lesions preceded flipper lesions. Oral lesions were also suspected in ZAC on 21 April but could not be confirmed, as the animal would not open its mouth on command. A single animal, NOR, developed vesicles, first noted on 21 April, but did not show other clinical signs of disease. The remaining five animals in the group showed no clinical evidence of infection.
Between 12 April and 25 June 1997, a total of 44 serum samples, five fecal samples, nine vesicular aspirates, five vesicular swabs, and four tissue samples were collected from the group, using techniques described above.
Virus isolation (VI)
Vesicular fluid samples were placed directly onto Vero cell (ATCC CRL 1587) culture monolayers in 25 cm 2 flasks (Costar, Cambridge, Massachusetts, USA) and IBRS-2 cell (DeCastro, 1964) culture monolayers in 16 ϫ 125 mm size roller tubes (Corning Glass Works, Corning, New York, USA) and incubated for 1 hr at 37C. Eagles minimum essential media with nonessential amino acids (EMEM-NEAA) (Bio Whittaker, Walkersville, Maryland, USA) containing 23 mcg/ml gentamicin (Sigma-Adlrich, Irvine, Kansas, USA) and ten percent fetal bovine serum (FBS) (NVSL, Ames, Iowa, USA) was added to each vessel and the vessels were incubated at 37C for seven days. The monolayers were examined daily for cytopathogenic effects (CPE). Cultures that did not exhibit CPE were frozen, thawed, and 1 ml of the cell-media slurry was inoculated into a second cell culture flask or tube, which was incubated and observed for an additional seven days. A third passage was made in an identical manner. Cultures exhibiting CPE were examined by the methods described below. Tissue samples were finely minced as a ten percent suspension in EMEM-NEAA supplemented to contain 30 mcg gentamicin/ml (EMEM-AB), and centrifuged at 200 ϫ g for 5 min. One ml supernatant was inoculated onto Vero and IBRS-2 monolayers, and the cultures were treated as described for vesicular fluid samples. The transportation medium from each fecal swab was centrifuged at 200 ϫ g for 5 min, and one ml supernatant placed onto Vero and IBRS-2 monolayers. After 1 hr at 37C, the inoculum was decanted, and the monolayer rinsed with 3 ml EMEM-AB, to decrease contamination with fecal bacteria. The EMEM-AB supplemented with ten percent FBS was added to each culture, and the cultures were incubated and treated as described for vesicular fluid samples.
Electron microscopy
Vesicular fluid samples and the supernatants of cell cultures exhibiting CPE were prepared for negative stain electron microscopy by floating formvar grids on a drop of the fluid for 30 minutes. The grids were blotted and transferred to a drop of 4% phosphotungstic acid, pH 7.2, for 10 min. After blotting and drying for 30 min, the grids were examined for the presence of viral-like particles in a Zeiss EM 10 electron microscope. Tentative identification of the genus of the virus was made by measurements of morphological features (Fig. 3) .
Virus identification
Electron micrographs were used to tentatively identify the virus genus in samples and cell culture isolates. Virus neutralization by spe-cific reference antisera (Reagents and Vaccine Section, FADDL, Greenport New York, USA) diluted to contain 20 antibody units 50% was used to identify the serotype of all cell culture isolates.
Serological tests
Antibodies to the caliciviruses SMSV1, 2, 4-13, vesicular exanthema of swine viruses 1934B, A48, B4, C52, D53, E54, F55, G55, H54, I55, J56, K54, bovine calicivirus Tillamook, and the new isolate FADDL 7005, were assayed in a virus neutralization test (VN) (O'Hara et al., 1998) , using 100 to 400 tissue culture infective doses 50% (TCID 50 ) of each calicivirus in 25 l EMEM-NEAA and 3 days incubation. Antibodies to bovine respiratory syncytial virus (BRSV) were assayed in a similar test using 100 to 400 TCID 50 BRSV in 25 l EMEM-NEAA, embryonic bovine lung cells (NVSL, Ames, Iowa, USA) and 3 days incubation. Antibodies to influenza viruses were assayed by the agar gel immunodiffusion test (NVSL, Ames, Iowa, USA).
Production of rabbit antiserum
Vero cell culture isolate, passage two, was treated with chloroform to remove potential contamination (Gwaltney et al., 1989) . Virus was propagated on Vero cells using serum-free medium. Virus in the third and fourth Vero cell passage, in serum-free medium, was used as antigen for rabbit immunization. Ten 150 cm 2 culture flasks (Corning Costar Corp., Cambridge, Massachusetts, USA) were inoculated with each virus passage and harvested 20 hr after inoculation, when CPE was complete. Cultures were frozen and thawed, clarified for 20 min at 2,000 ϫ g using a Beckman J6B centrifuge (Beckman Instruments, Palo Alto, California, USA). The suspension was filtered through a 0.45 nitrocellulose filter (Nalge Co., Rochester, New York, USA). In each of four tubes, 30 ml of viral suspension was pelleted through 5 ml of a 45% sucrose solution in 0.01 M trihydroxymethylaminomethane (TRIS) and 0.15 M sodium chloride cushion for 1 hr at 300,000 ϫ g using a fixed angle 60 TI rotor with a Beckman L8-70M ultracentrifuge (Beckman Instruments, Palo Alto, California, USA). The viral pellets were dissolved in 10 ml of Eagles minimum essential medium (Biowhittaker Inc. Walkersville, Maryland, USA) overnight at 4C on a rocker (Caframa Ltd. Wiarton, Ontario, Canada). The viral suspensions were pooled for rabbit inoculation. For the initial inoculation viral suspension was mixed with an equal volume of Freund's complete adjuvant (Difco Laboratories, Detroit, Michigan, USA) and 0.5 ml was administered in three sites IM, 0.2 ml in three sites SC and 1.2 ml was administered IP. Rabbits were prebled and then test-bled 5 wk after the first inoculation (2 ml) by the marginal ear vein. The rabbits were hyperimmunized 6 wk after the original inoculation by inoculating 0.5 ml of the viral suspension IV. The rabbits were bled by cannulating the middle ear artery 2 wk after hyperimmunization. Three wk after hyperimmunization, they were exsanguinated by cardiac puncture under general anesthesia induced by the IM injection of 1.5 ml Ketaset (Fort Dodge Laboratories, Inc, Fort Dodge, Iowa, USA) and 0.25 ml Xylazine (Fermenta Animal Health Co., Kansas City, Missouri, USA). Rabbits were euthanized by the IM injection of 6 ml of FATAL Plus (Vortech Pharmaceuticals Ltd., Dearborn, Michigan, USA). The antiserum was titrated for neutralizing antibody to FADDL 7005 as described above, and used in the VN test at a dilution containing 20 antibody units 50% to identify the serotype of the virus isolates. The antisera was also used in the VN test with known caliciviruses and found to be unreactive.
Indirect fluorescent antibody staining
A mouse monoclonal antibody designated as 14F7E6 that is specific for a group reactive epitope in all of the known vesicular exanthema of swine (VES) and San Miguel sea lion viruses (SMSVs) was obtained from the FADDL repository. The antibody was used at a working dilution of 1:80 in a standard indirect fluorescent antibody test system. Briefly, VES A48 and FADDL 7005 were used in tenfold dilutions to infect Vero cells in 8-chambered cell culture slides to obtain about 30 infected cells/field under 100ϫ magnification. The VES A48 served as the positive control and uninfected wells served as the negative control. A polyvalent anti-mouse IgG, IgA and IgM fluorescent antibody (Sigma, St. Louis, Missouri, USA) was used to detect mouse immunoglobulin.
Swine inoculation studies
Adult healthy swine were housed in biocontainment level 3ϩ animal facilities at FADDL and were observed daily. Animals were anesthetized for inoculation, examination, photographing for lesions and collection of tissues by IM injection of 3 mg/kg Telazol (Fort Dodge Lab, Inc, Fort Dodge, Iowa, USA), 8 mg/kg Ketamine (ASCO, Fort Dodge, Iowa USA) and 4 mg/kg Xylazine (Fermenta Animal Healthco, Kansas City, Missouri, USA). Animal #21 was bled and then inoculated intradermally in the snout and right front foot with 0.5 ml Vero cell culture passage two of FADDL 7005. A second animal (#22) was bled for serology and introduced into the room on two days post inoculation (dpi). A third pig (#25) was bled for serology and introduced into the room on 6 dpi. Additional blood was drawn for serology from animal #25 on 7 dpi, 14 dpi, 21 dpi, and 27 dpi.
RESULTS
Sea lion clinical cases
The results of calicivirus serology, virus isolations, and observed clinical signs in the affected sea lions are presented as Table 1. All animals were negative for antibodies to BRSV, influenza viruses, and all caliciviruses except FADDL 7005. Clinical signs lasted 4 to 20 days in affected animals. Four of them, NIC, ZAC, LIB, DUK, developed oral and extremity vesicles, anorexia, and were reluctant to perform learned behaviors. One animal, NOR, developed vesicles but maintained a normal appetite and behavior. Serum samples from sea lions exhibiting any combination of clinical signs had serum neutralizing antibody titers to FADDL 7005 (Table 2). The maximum recorded titer was Ն1:3,600 seen in the index case. Blood samples were not available from NOR during the outbreak. Titers decreased after clinical recovery. Two sea lions that did not develop clinical signs, GRE and NEW, had measurable titers to FADDL 7005 of 1: 290 and 1:110 respectively. All remaining animals had no measurable titer against 
Swine inoculation and transmission studies
A summary of virus isolations and the presence or absence of lesions or fever (rectal temperature of Ն40C or greater) in experimental swine is presented in Table  3 . The inoculated animal, #21, developed vesicular disease by the afternoon of 2 dpi (Figs. 4, 5) . Animal #22 was exposed to animal #21 at that time and developed vesicular disease on 1 days post exposure (dpe). The third animal, #25, was introduced on 6 dpi and remained clinically normal. All animals (#21, #22, and #25) were negative for neutralizing antibody to FADDL 7005 on 0 dpi or 0 dpe. Animal #21 quickly developed a high titer of 1: 5,750 at 7 dpi, which remained fairly stable throughout the study, with titers of 1: 4,550, 1:7,250, and 1:9,100 on 14, 21, and 27 dpi respectively. Animal #22 responded more slowly, with titers of 1:570, 1:5,750 and 1:910 on 6, 14, and 25 dpe respectively. Animal #25 developed a low titer over the course of the study, with titers of 1:71, 1:360, and 1:230 on 7, 14, and 20 dpe.
Indirect fluorescent antibody study
Specific staining, typical of the group reactive epitope of calicivirus seen with the monoclonal antibody 14F7E6, was observed with VES A48 and FADDL 7005. Uninfected cell cultures showed no staining.
DISCUSSION
The California sea lions in this group were infected with a previously uncharacterized calicivirus, FADDL 7005. The source of the calicivirus infection in this group of animals was not determined. It is possible that local wild sea lions exposed the group to the calicivirus. Wild sea lions are occasionally observed near the enclosures or approach the animals while working at sea. We observed vesicular lesions on a wild yearling male California sea lion that stranded at our facility in March 1997. A swab of vesicular fluid from this animal was submitted to FADDL and was negative on virus isolation attempts. However, the swab had been stored for a prolonged time at room temperature prior to submission. It also is interesting that vesicular lesions are rare in sea lions presenting as stranded animals to the nearby San Diego Sea World facility (T. Reidarson, pers. comm.). A marine calicivirus has been isolated from the teleost fish (Girella nigricans) (Smith et al., 1998) , but antiserum to the fish virus was not able to be obtained for purposes of comparing it to FADDL 7005. The opaleye and other fish species have been postulated as a source for pinniped infection Akers, 1976, and Smith et al., 1998) . Girella nigricans is not included in the diets of our working animals, but other southern California species are eaten by our animals. To date we have not attempted virus isolation from any species of our food fishes.
We note the development of oral vesicles as the primary lesion in this epizootic. This is in contrast to the clinical description provided by Gage et al. (1990) where lesions primarily involved the flippers. It is possible, however, that oral lesions had resolved in stranded animals by the time of presentation to a treatment facility.
The results of our swine inoculation and transmission studies clearly demonstrate that FADDL 7005, isolated from California sea lions in southern California, is infectious for swine and causes a vesicular syndrome indistinguishable from vesicular exanthema of swine.
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